Medical therapies for postoperative Crohn’s disease
Author:
Affiliation:
1. Cleveland Clinic - Internal Medicine, 9500 Euclid Ave, Cleveland, OH 44195, USA
2. Cleveland Clinic - Gastroenterology, Hepatology, and Nutrition, Cleveland, OH, USA
Abstract
Publisher
SAGE Publications
Subject
Gastroenterology
Link
http://journals.sagepub.com/doi/pdf/10.1177/1756284821993581
Reference89 articles.
1. Hospitalisations and surgery in Crohn's disease
2. Outcomes of Patients With Crohn's Disease Improved From 1988 to 2008 and Were Associated With Increased Specialist Care
3. Increasing Incidences of Inflammatory Bowel Disease and Decreasing Surgery Rates in Copenhagen City and County, 2003–2005: A Population-Based Study from the Danish Crohn Colitis Database
4. Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates
5. Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases: a population-based interrupted time series study
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy of Ustekinumab and Vedolizumab Among Postoperative Crohn’s Disease Patients as Postoperative Prophylaxis and Rescue Therapy: Real-world Data;Inflammatory Bowel Diseases;2024-07-02
2. Bowel Resection Margins in Crohn's Disease: Do They Matter?;Clinics in Colon and Rectal Surgery;2024-04-25
3. Clinical Update on the Prevention and Management of Postoperative Crohn’s Disease Recurrence;Current Gastroenterology Reports;2024-01-16
4. Anti-TNF Agents and New Biological Agents (Vedolizumab and Ustekinumab) in the Prevention and Treatment of Postoperative Recurrence After Surgery in Crohn’s Disease;Drugs;2023-07-28
5. Saccharomyces cerevisiae prevents postoperative recurrence of Crohn's disease modeled by ileocecal resection in HLA-B27 transgenic rats;World Journal of Gastroenterology;2023-02-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3